Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 20.62% vs -0.97% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 1,851.25% vs -22.33% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 105.92% vs 117.61% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 4,100.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Mochida Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -9.35% vs 14.63% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 20.62% vs -0.97% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -37.21% vs 26.71% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1,851.25% vs -22.33% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 2.46% vs 6.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 105.92% vs 117.61% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 44.83% vs 2,800.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4,100.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






